Skip to content

Dorzolamide

Trusopt (dorzolamide) is a small molecule pharmaceutical. Dorzolamide was first approved as Trusopt on 1994-12-09. It is used to treat open-angle glaucoma in the USA. It is known to target carbonic anhydrase 7, carbonic anhydrase 12, carbonic anhydrase 14, carbonic anhydrase 1, and carbonic anhydrase 4.
Trade Name Trusopt
Common Name Dorzolamide
Indication open-angle glaucoma
Drug Class Carbonic anhydrase inhibitors
Dorzolamide
Get full access now